Drug labeling and ingredient reviews. Subpart b labeling requirements for prescription drugs andor insulin 20150 statement of identity. Labeling Dietary Supplements This guidance is intended to assist applicants in complying with the content and format requirements of labeling for human prescription drug and biological products under 21 cfr 20156d and 20157.
0 Yorumlar